(Q37965274)

26 August 2017

1 reference

title

Tumor necrosis factor: an update on basic research and clinical applications (English)

1 reference

26 August 2017

M Schleuning

1

1 reference

26 August 2017

R Munker

series ordinal

2

1 reference

26 August 2017

publication date

1 September 1990

1 reference

26 August 2017

published in

Klinische Wochenschrift

1 reference

26 August 2017

volume

68

1 reference

26 August 2017

issue

17

1 reference

26 August 2017

page(s)

841-846

1 reference

Tumor necrosis factor induces hemorrhagic necrosis of a sarcoma

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF01662779

Tumour necrosis factor in man: clinical and biological observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01662779

Interleukin-2-induced tumor necrosis factor-alpha (TNF-alpha) gene expression in human alveolar macrophages and blood monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01662779

Dyscoordinate Expression of Tumor Necrosis Factor-alpha by Human Blood Monocytes and Alveolar Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01662779

Monocyte-conditioned medium, interleukin-1, and tumor necrosis factor stimulate the acute phase response in human hepatoma cells in vitro

21 January 2018

1 reference

12 December 2020

Immunoregulation and production of tumor necrosis factor alpha by human thymocytes

1 reference

12 December 2020

Tumour necrosis factor and lymphotoxin genes map close to H–2D in the mouse major histocompatibility complex

1 reference

12 December 2020

Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis.

1 reference

12 December 2020

Cachectin/tumor necrosis factor mediates changes of skeletal muscle plasma membrane potential

1 reference

12 December 2020

Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes

1 reference

12 December 2020

Cachectin: more than a tumor necrosis factor

1 reference

12 December 2020

Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors

1 reference

12 December 2020

Effect of tumor necrosis factor alpha on mitogen-activated human B cells

1 reference

12 December 2020

Intralesional application of recombinant human tumor necrosis factor alpha induces local tumor regression in patients with advanced malignancies

1 reference

12 December 2020

Antiviral effects of recombinant tumour necrosis factor in vitro

1 reference

12 December 2020

Tumor necrosis factor and the acute metabolic response to tissue injury in man

1 reference

12 December 2020

Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-alpha

1 reference

12 December 2020

Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex

1 reference

12 December 2020

Tumors secreting human TNF/cachectin induce cachexia in mice

1 reference

12 December 2020

Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies

1 reference

12 December 2020

A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor

1 reference

12 December 2020

Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes

1 reference

12 December 2020

A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF

1 reference

12 December 2020

Tumor necrosis factor alpha/cachectin is a growth factor for thymocytes. Synergistic interactions with other cytokines

1 reference

12 December 2020

Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic Study

1 reference

12 December 2020

Phase I study of intratumoral application of recombinant human tumor necrosis factor

1 reference

12 December 2020

In vivo hematopoietic effects of tumor necrosis factor-alpha in normal and erythroleukemic mice: characterization and therapeutic applications

1 reference

12 December 2020

Asbestos fibers and silica particles stimulate rat alveolar macrophages to release tumor necrosis factor. Autoregulatory role of leukotriene B4

1 reference

12 December 2020

Expression of tumor necrosis factor receptors on human monocytes and internalization of receptor bound ligand

1 reference

12 December 2020

Enhancement of in vivo immune response by tumor necrosis factor

1 reference

12 December 2020

Raised serum levels of tumour necrosis factor in parasitic infections

1 reference

12 December 2020

Cyclosporine does not inhibit the early transducing signals generated by the activation of human thymocytes

1 reference

12 December 2020

Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody

1 reference

12 December 2020

Recombinant tumor necrosis factor causes activation of human granulocytes.

1 reference

12 December 2020

Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis

1 reference

12 December 2020

A phase I clinical trial of recombinant human tumor necrosis factor

1 reference

12 December 2020

Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation

1 reference

12 December 2020

Structure of tumour necrosis factor

1 reference

12 December 2020

Decrease of natural killer cell activity and monokine production in peripheral blood of patients treated with recombinant tumor necrosis factor

1 reference

12 December 2020

The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity

1 reference

12 December 2020

Characterization of the antitumor activities of human tumor necrosis factor-alpha and the comparison with other cytokines: induction of tumor-specific immunity

1 reference

12 December 2020

EVIDENCE FOR TUMOUR NECROSIS FACTOR/CACHECTIN PRODUCTION IN CANCER

1 reference

12 December 2020

Phase I trial of intramuscularly administered tumor necrosis factor in patients with advanced cancer

1 reference

12 December 2020

Plasma membrane-associated tumor necrosis factor. A non-integral membrane protein possibly bound to its own receptor

1 reference

12 December 2020

Downregulation of tumor necrosis factor (TNF) sensitivity via modulation of TNF binding capacity by protein kinase C activators

1 reference

12 December 2020

Detection of circulating tumor necrosis factor after endotoxin administration.

1 reference

12 December 2020

Tumor necrosis factor is the major monocyte product that increases complement receptor expression on mature human neutrophils

1 reference

12 December 2020

Tumor necrosis factor: recent advances

1 reference

12 December 2020

Inhibition by chlorpromazine of lymphokine-specific mRNA expression in human thymocytes

1 reference

12 December 2020

Preparation and characterization of monoclonal antibodies directed against antigenic determinants of recombinant human tumour necrosis factor (rTNF)

1 reference

12 December 2020

Nonhematopoietic cells selected for resistance to tumor necrosis factor produce tumor necrosis factor

1 reference

12 December 2020

Induction by E1A oncogene expression of cellular susceptibility to lysis by TNF.

1 reference

12 December 2020

Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities

1 reference

12 December 2020

Tumor necrosis factor alpha induces early morphologic and metabolic alterations in Friend leukemia cell tumors and fibrosarcomas in mice

1 reference

12 December 2020

Immunohistochemical demonstration of cytoplasmic and membrane-associated tumor necrosis factor in murine macrophages

1 reference

12 December 2020

A human inhibitor of tumor necrosis factor alpha

1 reference

12 December 2020

Cachectin/tumor necrosis factor: a possible mediator of cancer anorexia in the rat

1 reference

12 December 2020

Tumor necrosis factor and disease severity in children with falciparum malaria

1 reference

12 December 2020

Systemic versus local therapy with recombinant tumor necrosis factor-alpha (r-TNF-alpha) in patients with advanced tumors

1 reference

12 December 2020

The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells

1 reference

12 December 2020

Modulation of endogenous hormone action by recombinant human tumor necrosis factor

1 reference

12 December 2020

A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients

1 reference

12 December 2020

Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease

1 reference

12 December 2020

Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation

1 reference

12 December 2020

Tumor necrosis factor and lymphotoxin gene expression in human tumor cell lines.

1 reference

12 December 2020

Genetic analysis of the human tumor necrosis factor alpha/cachectin promoter region in a macrophage cell line

1 reference

12 December 2020

Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes

1 reference

12 December 2020

Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells

1 reference

12 December 2020

Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism

1 reference

12 December 2020

Human vascular smooth muscle cells. Target for and source of tumor necrosis factor

1 reference

12 December 2020

Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons

1 reference

12 December 2020

Induction of tumor necrosis factor expression and resistance in a human breast tumor cell line

1 reference

12 December 2020

Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1

1 reference

12 December 2020

Monoclonal antibodies to human tumor necrosis factors alpha and beta: application for affinity purification, immunoassays, and as structural probes

1 reference

12 December 2020

Cytokines as mediators of graft-versus-host disease

1 reference

12 December 2020

Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism

1 reference

12 December 2020

Growth-promoting effect of recombinant interleukin 1 and tumor necrosis factor for a human astrocytoma cell line.

1 reference

12 December 2020

Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura

1 reference

12 December 2020

Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells

1 reference

12 December 2020

Plasma tumor necrosis factor and mortality in critically ill septic patients

1 reference

12 December 2020

Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells

1 reference

12 December 2020

Recombinant human TNF alpha stimulates production of granulocyte colony-stimulating factor

1 reference

12 December 2020

Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection

1 reference

12 December 2020

Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor/cachectin-responsive genes

1 reference

12 December 2020

Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cells

1 reference

12 December 2020

Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure

1 reference

12 December 2020

Quantification and characterization of high-affinity membrane receptors for tumor necrosis factor on human leukemic cell lines

1 reference

12 December 2020

Shock and tissue injury induced by recombinant human cachectin

1 reference

12 December 2020

Regulation of tumor necrosis factor gene expression in colorectal adenocarcinoma: in vivo analysis by in situ hybridization

1 reference

12 December 2020

Merkel cell carcinoma. A successful treatment with tumor necrosis factor

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01662779

1 reference

26 August 2017

1 reference